GuidelinesIMCI
Cotrimoxazole (Age 2 months up to 5 years)
IMCI - Child (Age 2 months up to 5 years)
Give Cotrimoxazole Once Daily as Prophylaxis
- Give to all children with HIV infection (criteria for stopping in children on ART are shown below)
|
Indications
|
When to start
|
When to stop
|
|
HIV-infected infants (< 1 year of age)
|
From 6 weeks of age
|
Continue until 1 year of age, regardless of clinical stage and CD4 count
|
|
HIV-positive children 1-5 years of age.
|
All symptomatic children: WHO clinical stage 2, 3 or 4
OR CD4 <25% / CD4 <500 cells/ μl. |
Stop if clinically well on ART and CD4 ≥25% or ≥500 cells/μl on ≥2 occasions 3-6 months apart
Recommence if CD4 drops <200 cells/μl, if ART fails or if new opportunistic infection develops
|
|
HIV-positive children ≥ 5 years of age, adolescents and adults.
|
Start if CD4 <200 cell/μl
OR
Clinical stage 3 or 4 disease (including TB) |
Stop if clinically well on ART and CD4 ≥200 cells/μl on ≥2 occasions 3-6 months apart. Recommence if CD4 drops below 200 cells/ μl
|
|
Weight
|
Cotrimoxazole syrup
(200/40 mg per 5 ml)
|
Cotrimoxazole tablet
400/80 mg
|
Cotrimoxazole tablet
800/160 mg
|
|
2.5 - < 5 kg
|
2.5 ml
|
1/4 tablet
|
|
|
5 - < 14 kg
|
5 ml
|
1/2 tablet
|
|
|
14 - < 30 kg
|
10 ml
|
1 tablet
|
1/2 tablet
|
|
≥ 30 kg
|
|
2 tablets
|
1 tablet
|
Click here to open the above content in the original PDF view
Integrated Management of Childhood Illness 2022; Child (Age 2 months up to 5 years); Oral Medicines; Cotrimoxazole
Last checked for updates: June 2023